Preferred Label : SARS-CoV-2 variants;
MeSH synonym : COVID-19 Virus variants;
MeSH hyponym : 501Y.V2 SARS-CoV-2 variant; SARS-CoV-2 variant 501Y.V2; SARS-CoV-2 501Y.V2; B.1.525 SARS-CoV-2; SARS-CoV-2 B.1.525; SARS-CoV-2 A.23.1; A.23.1 SARS-CoV-2 variant; A.1.177 SARS-CoV-2; SARS-CoV-2 A.1.177; SARS-CoV-2 614G variant; SARS-CoV-2 variant D614G; SARS-CoV-2 D614G; D614G SARS-CoV-2 variant; SARS-CoV-2 P.2; SARS-CoV-2 variant P.2; P.2 SARS-CoV-2 variant; SARS-Cov-2 20I-501Y.V1; SARS-Cov-2 variant VUI-202012-01; SARS-CoV-2 VUI-202012-01; SARS Coronavirus 2 variant VUI-202012-01; SARS Coronavirus 2 VUI-202012-01; SARS-Cov-2 variant VUI-202012 01; Severe Acute Respiratory Syndrome Coronavirus 2 variant 202012 01; 20I 501Y.V1; 20I501Y.V1; Severe Acute Respiratory Syndrome Coronavirus 2 variant 202012-01; SARS-Cov-2 VOC 202012-01; SARS-CoV-2 B.1.1.7; SARS-Cov-2 variant of concern 202012-01; COVID-19 Virus variant 202012-01; COVID-19 Virus variant 202012 01; SARS-CoV-2 variant P.1; 20J501Y.V3; 20J 501Y.V3; P.1 SARS-CoV-2 variant; SARS-CoV-2 P.1; SARS-CoV-2 cluster 5; SARS-CoV-2 variant cluster 5; SARS-CoV-2 mink-associated variant; cluster 5 SARS-CoV-2 variant; L452R SARS-CoV-2 variant; SARS-CoV-2 452R variant; CAL.20C variant; CAL.20C; SARS-CoV-2 CAL.20C variant; SARS-CoV-2 L452R; SARS-CoV-2 variant L452R; B.1.351 SARS-CoV-2 variant; SARS-CoV-2 variant 20H 501Y.V2; 20H501Y.V2; SARS-CoV-2 variant 20H-501Y.V2; SARS-CoV-2 B.1.351; 20H 501Y.V2; SARS-CoV-2 B.1.640.2 variant; SARS-CoV-2 B.1.640.2; gamma variant SARS-CoV-2; SARS-CoV-2 gamma variant; SARS-CoV-2 20J variant; zeta variant SARS-CoV-2; SARS-CoV-2 zeta variant; SARS-CoV-2 20B S.484K variant; eta variant SARS-CoV-2; SARS-CoV-2 20A S484K variant; SARS-CoV-2 21D variant; SARS-CoV-2 eta variant; B.1.427 SARS-CoV-2 variant; SARS-CoV-2 20C S.452R variant; SARS-CoV-2 B.1.429; B.1.429 SARS-CoV-2 variant; SARS-CoV-2 epsilon variant; SARS-CoV-2 B.1.427; SARS-CoV-2 B.1.429 variants; delta variant SARS-CoV-2; SARS-CoV-2 20C S.452R; SARS-CoV-2 21A variant; SARS-CoV-2 delta variant; B.1.617.2 SARS-CoV-2 variant; SARS-CoV-2 20B S265C variant; SARS-CoV-2 theta variant; iota variant SARS-CoV-2; SARS-CoV-2 21F variant; SARS-CoV-2 iota variant; B.1.526 SARS-CoV-2 variant; B.1.617.1 SARS-CoV-2 variant; kappa variant SARS-CoV-2; SARS-CoV-2 21B variant; SARS-CoV-2 21A S154K variant; SARS-CoV-2 B.1.617.1; SARS-CoV-2 kappa variant; SARS-CoV-2 484K variants; SARS-CoV-2 484K variant; SARS-CoV-2 E484K variant; lambda variant SARS-CoV-2; SARS-CoV-2 lambda variant; SARS-CoV-2 21G variant; SARS-CoV-2 variant, 20E (EU1); 20E SARS-CoV-2; SARS-CoV-2 20E; SARS-CoV-2 variant, 20E; AY.4.2 SARS-CoV-2 variant; SARS-CoV-2 R.1; R.1 variant SARS-CoV-2; SARS-CoV-2 B.1.621; SARS-CoV-2 B.1.621 variant; B.1.621 variant SARS-CoV-2; SARS-CoV-2 Mu; Mu variants SARS-CoV-2; SARS-CoV-2 B.1.621.1; B.1.621.1 variant SARS-CoV-2; SARS-CoV-2 21H variant; SARS-CoV-2 omicron variant; SARS-CoV-2 21K variant; SARS Coronavirus 2 variant B.1.1.529; COVID-19 Virus variant B.1.1.529; SARS-CoV-2 B.1.1.529; omicron SARS-CoV-2 variant; B.1.1.529 SARS-CoV-2 variant; alpha variant SARS-CoV-2; SARS-CoV-2 alpha variant; SARS-CoV-2 20I variant; SARS-CoV-2 501Y.V2 variant; beta variant SARS-CoV-2; SARS-CoV-2 beta variant; SARS-CoV-2 20H variant; SARS-CoV-2 omicron subvariant BA.2; SARS-CoV-2 BA.2 variant; SARS-CoV-2 B.1.1.529 variant; SARS-CoV-2 BA.1 variant; SARS-CoV-2 XBB subvariant; Omicron subvariant XBB, SARS-CoV-2; SARS-CoV-2 EG.5; XBB.1.5 omicron subvariant;
Origin ID : C000711908;
UMLS CUI : C5433390;
Automatic exact mappings (from CISMeF team)
- Currated CISMeF NLP mapping
- MeSH term(s) associated for indexing
- Record concept(s)
- Semantic type(s)
- Virus [UMLS semantic type]
- UMLS correspondences (same concept)
- Validated automatic mappings to BTNT
https://www.who.int/fr/news/item/08-03-2022-interim-statement-on-covid-19-vaccines-in-the-context-of-the-circulation-of-the-omicron-sars-cov-2-variant-from-the-who-technical-advisory-group-on-covid-19-vaccine-composition-(tag-co-vac)-08-march-2022
2022
false
false
false
Switzerland
COVID-19
COVID-19 Vaccines
scientific and technical information
Techniques
Vaccinia
Techniques
SARS-CoV-2 variants
Vacuum-Assisted closure
preventive immunization/medication
Techniques
Techniques
SARS-CoV-2 variants
mars
Vaccins
vaccination
registries
vaccination, nos
vaccines
vaccine, nos
world health organization
focus groups
SARS-CoV-2
vaccinia, nos
---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=1150
2022
France
COVID-19
public health guidelines
diffusion
viruses
isolation procedure
interpersonal relations
persons
SARS-CoV-2 variants
Virus
Severe acute respiratory syndrome-related coronavirus
snacks
dermatomyositis
Viruses
SARS-CoV-2
SARS-CoV-2 variants
judgment
virus, nos
---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=1147
2022
false
false
false
France
COVID-19
public health guidelines
Severe acute respiratory syndrome-related coronavirus
wrestling
viruses
virus, nos
SARS-CoV-2 variants
SARS-CoV-2
judgment
SARS-CoV-2 variants
research report
masks
Virus
Control
albumin/globulin ratio
Viruses
---
https://www.who.int/fr/news/item/11-01-2022-interim-statement-on-covid-19-vaccines-in-the-context-of-the-circulation-of-the-omicron-sars-cov-2-variant-from-the-who-technical-advisory-group-on-covid-19-vaccine-composition
2022
false
false
false
Switzerland
COVID-19
COVID-19 Vaccines
scientific and technical information
SARS-CoV-2 variants
Vacuum-Assisted closure
vaccination, nos
Vaccins
Techniques
preventive immunization/medication
Techniques
vaccines
SARS-CoV-2
vaccine, nos
vaccinia, nos
vaccination
Techniques
registries
Techniques
Vaccinia
SARS-CoV-2 variants
world health organization
focus groups
---
https://recalls-rappels.canada.ca/fr/avis-rappel/casirivimab-et-imdevimab-risque-eleve-echec-therapeutique-en-raison-circulation-du
2022
false
false
false
Canada
French
English
pharmacovigilance note
COVID-19
casirivimab and imdevimab drug combination
risk
drug combinations
imdevimab
casirivimab
treatment failure
canada
SARS-CoV-2 variants
---
https://ansm.sante.fr/actualites/traitements-par-anticorps-monoclonaux-actuellement-disponibles-contre-la-covid-19-et-utilisation-selon-les-variants
2022
false
false
false
France
French
guidelines for drug use
COVID-19
COVID-19
antibodies, monoclonal
Post-Exposure prophylaxis
Pre-Exposure Prophylaxis
casirivimab and imdevimab drug combination
cilgavimab and tixagevimab drug combination
SARS-CoV-2 variants
casirivimab and imdevimab drug combination
---
Sotrovimab for Injection - Risk of Treatment Failure due to Circulation of SARS-CoV-2
Omicron BA.2 Subvariant
https://recalls-rappels.canada.ca/fr/avis-rappel/sotrovimab-pour-injection-risque-echec-therapeutique-en-raison-circulation-du-ba2-sous
2022
false
false
false
Canada
French
English
COVID-19
risk
pharmacovigilance note
treatment failure
sotrovimab
SARS-CoV-2 variants
new coronavirus variant
infusions, intravenous
sotrovimab
---
https://www.inspq.qc.ca/covid-19/donnees/variants
2021
false
false
false
Canada
COVID-19
SARS-CoV-2 variants
scientific and technical information
dataset
quebec
Severe acute respiratory syndrome-related coronavirus
---
https://solidarites-sante.gouv.fr/IMG/pdf/reply_dgs-urgent_123_variant_b.1.1.529-omicron.pdf
2021
false
false
false
France
COVID-19
SARS-CoV-2 variants
public health guidelines
screening
reinforcement, nos
mass screening
Reinforcement, Psychology
weights and measures
measures
---
https://www.santepubliquefrance.fr/les-actualites/2021/point-sur-le-variant-du-sars-cov-2-omicron-b.1.1.529
2021
France
COVID-19
scientific and technical information
SARS-CoV-2 variants
SARS-CoV-2 variants
SARS-CoV-2
---
https://apps.who.int/iris/bitstream/handle/10665/345912/WHO-2019-nCoV-surveillance-variants-2021.1-fre.pdf
2021
Switzerland
COVID-19
public health guidelines
organization and administration
orientation, nos
orientation
SARS-CoV-2 variants
SARS-CoV-2
SARS-CoV-2 variants
---
https://presse.inserm.fr/covid-19-etude-sur-lefficacite-de-la-memoire-immunitaire-apres-vaccination-arnm-pour-reconnaitre-les-variants-du-sars-cov2/43817
2021
false
false
false
France
French
journal article
vaccines, synthetic
SARS-CoV-2
COVID-19
immunologic memory
vaccination
mRNA Vaccine
SARS-CoV-2 variants
vaccine potency
---
https://apps.who.int/iris/bitstream/handle/10665/345277/WHO-2019-nCoV-vaccine-effectiveness-variants-2021.1-fre.pdf
2021
Switzerland
public health guidelines
COVID-19
COVID-19 Vaccines
evaluation studies as topic
orientation, nos
orientation
leadership
SARS-CoV-2 variants
SARS-CoV-2 variants
guideline
vaccine potency
SARS-CoV-2
guideline
---
https://publications.msss.gouv.qc.ca/msss/document-003124/
2021
false
false
false
Canada
COVID-19
public health guidelines
SARS-CoV-2 variants
organizers, embryonic
organization
SARS-CoV-2
Organization
SARS-CoV-2 variants
organizations
Organization
leadership
guideline
guideline
pneumonia, viral
coronavirus infections
pandemics
---
https://www.has-sante.fr/jcms/p_3272617/fr/avis-n-2021-0044/ac/seesp-du-17-juin-2021-du-college-de-la-haute-autorite-de-sante-relatif-a-la-vaccination-en-anneau-et-la-vaccination-reactive-devant-l-emergence-de-variants-du-sars-cov-2
2021
false
false
false
France
COVID-19
new coronavirus variant
COVID-19 Vaccines
public health guidelines
judgment
Vaccins
attitude to health
SARS-CoV-2 variants
Fracture-dislocation
Vaccinia
Acanthoma
schools
health
preventive immunization/medication
vaccination
vaccination
ring
SARS-CoV-2
vaccinia virus vaccine
health
---
https://www.santepubliquefrance.fr/presse/2021/etude-comcor-analyse-de-l-efficacite-des-vaccins-a-arn-messager-sur-les-variants-alpha-et-beta-du-sars-cov-2-en-france
2021
false
false
false
France
COVID-19
mRNA Vaccines
scientific and technical information
SARS-CoV-2 variants
France
beta, nos
France
vaccine, nos
messenger rna
vaccinia, nos
rna, messenger
France
Vaccins
french
vaccine potency
Vaccinia
vaccination, nos
SARS-CoV-2 variants
France
vaccination
france
data collection
preventive immunization/medication
SARS-CoV-2
COVID-19 Vaccines
SARS-CoV-2 mRNA vaccine
---
